Patient demographics and preoperative characteristics
| Phaco-deep sclerectomy | Phaco-trabeculectomy | p Value | |
|---|---|---|---|
| ACG, angle closure glaucoma; ARMD, age related macular degeneration; NTG, normal tension glaucoma; POAG, primary open angle glaucoma; PXF, pseudoexfoliation. | |||
| Number of eyes | 59 | 38 | |
| Age (years) (SD) | 78 (8.5) | 78 (8) | 0.55 |
| Male/female | 34/25 | 19/19 | 0.59 |
| Race | |||
| White | 54 (91.5%) | 36 (94.7 %) | |
| Afro-Caribbean | 3 (5.1%) | 2 (5.3%) | |
| Indian | 2 (3.4%) | ||
| Diagnosis | |||
| POAG | 47 (79.7%) | 27 (71.1%) | 0.46 |
| NTG | 5 (8.5%) | 7 (18.4%) | |
| PXF | 6 (10.1%) | 1 (2.6%) | |
| Steroid induced ACG | 1(1.7%) | 3 (7.9%) | |
| Co-existing ocular pathology | |||
| ARMD | 4 | 3 | |
| Retinitis pigmentosa | 1 | 0 | |
| Epiretinal membrane | 1 | 1 | |
| High myopia | 3 | 0 | |
| Diabetic retinopathy | 1 | 1 | |
| Chronic anterior uveatis | 1 | 0 | |
| Ocular surface disorder | 3 | 1 | |
| Previous laser | 0.29 | ||
| Peripheral iridotomy | 1 (1.7%) | 3 (7.9%) | |
| Laser trabeculoplasty | 1 (1.7%) | 1 (2.6%0 | |
| Previous surgery | |||
| Trabeculectomy | 3 (5.1%) | 3 (7.8%) | 0.89 |
| RD surgery | 1 (1.7%) | 1 ((2.6%) | |
| Glaucoma medications | |||
| Median | 2 | 2 | 0.84 |
| Range | 1–4 | 0–4 | |
| IOP control before surgery | |||
| Uncontrolled IOP (mm Hg) | 31 (81.6%) | 46 (78%) | 0.86 |
| Controlled IOP (mm Hg) | 7 (18.4%) | 13 (22%) | |
| Mean follow up (months) (SD) | 16.0 (9.0) | 19.4 (7.6) | 0.054 |
| Target IOP (mm Hg) (SD) | 14.8 (1.8) | 13.6 (1.2) | 0.001 |